Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 11 | 2025 | 343 | 2.710 |
Why?
|
| Ubiquinone | 3 | 2025 | 17 | 1.200 |
Why?
|
| Ammonia | 2 | 2017 | 13 | 1.150 |
Why?
|
| Oxygen | 3 | 2025 | 313 | 1.110 |
Why?
|
| Fumarates | 2 | 2025 | 10 | 1.000 |
Why?
|
| Electron Transport | 2 | 2025 | 35 | 1.000 |
Why?
|
| Electrons | 2 | 2025 | 34 | 1.000 |
Why?
|
| Nucleotides | 4 | 2025 | 44 | 0.820 |
Why?
|
| Adipose Tissue, Brown | 4 | 2025 | 111 | 0.760 |
Why?
|
| Energy Metabolism | 4 | 2025 | 359 | 0.750 |
Why?
|
| Thermogenesis | 4 | 2025 | 116 | 0.610 |
Why?
|
| Adipogenesis | 3 | 2024 | 71 | 0.590 |
Why?
|
| Glutamate Dehydrogenase | 1 | 2017 | 1 | 0.580 |
Why?
|
| Isotope Labeling | 1 | 2017 | 68 | 0.570 |
Why?
|
| Chromatography, Liquid | 1 | 2017 | 126 | 0.550 |
Why?
|
| Animals | 24 | 2025 | 19650 | 0.540 |
Why?
|
| Mice | 18 | 2025 | 10294 | 0.520 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 295 | 0.510 |
Why?
|
| Oxidation-Reduction | 6 | 2024 | 303 | 0.480 |
Why?
|
| Succinate Dehydrogenase | 3 | 2025 | 15 | 0.470 |
Why?
|
| Mice, Inbred C57BL | 9 | 2025 | 3231 | 0.460 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 4 | 2023 | 50 | 0.460 |
Why?
|
| Pyrimidines | 4 | 2025 | 131 | 0.440 |
Why?
|
| Mitochondrial Proteins | 2 | 2025 | 100 | 0.400 |
Why?
|
| Glutamine | 3 | 2023 | 46 | 0.380 |
Why?
|
| Breast Neoplasms | 3 | 2025 | 1118 | 0.360 |
Why?
|
| Neoplasms | 3 | 2024 | 1231 | 0.320 |
Why?
|
| Cell Line, Tumor | 6 | 2024 | 1368 | 0.310 |
Why?
|
| Isocitrate Dehydrogenase | 3 | 2025 | 21 | 0.300 |
Why?
|
| Hypoxia | 2 | 2025 | 112 | 0.270 |
Why?
|
| Glucose | 3 | 2024 | 445 | 0.270 |
Why?
|
| Humans | 19 | 2025 | 59374 | 0.250 |
Why?
|
| Glutarates | 2 | 2022 | 10 | 0.240 |
Why?
|
| Ergothioneine | 1 | 2025 | 1 | 0.240 |
Why?
|
| Sulfurtransferases | 1 | 2025 | 1 | 0.240 |
Why?
|
| Metabolic Flux Analysis | 1 | 2025 | 6 | 0.240 |
Why?
|
| Mitochondria, Muscle | 1 | 2025 | 13 | 0.240 |
Why?
|
| Aneuploidy | 1 | 2025 | 40 | 0.230 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2024 | 17 | 0.230 |
Why?
|
| Physical Conditioning, Animal | 1 | 2025 | 38 | 0.230 |
Why?
|
| DNA Damage | 2 | 2024 | 279 | 0.220 |
Why?
|
| Apoptosis | 3 | 2024 | 1033 | 0.220 |
Why?
|
| Signal Transduction | 7 | 2025 | 2903 | 0.220 |
Why?
|
| Selenium | 1 | 2024 | 25 | 0.220 |
Why?
|
| Uridine Diphosphate Glucuronic Acid | 1 | 2023 | 9 | 0.220 |
Why?
|
| Superoxides | 1 | 2023 | 69 | 0.210 |
Why?
|
| S-Adenosylmethionine | 1 | 2023 | 27 | 0.200 |
Why?
|
| Hypertension, Pulmonary | 1 | 2024 | 92 | 0.200 |
Why?
|
| Stress, Physiological | 1 | 2024 | 185 | 0.200 |
Why?
|
| Obesity | 3 | 2025 | 1166 | 0.190 |
Why?
|
| Leucine | 1 | 2022 | 61 | 0.190 |
Why?
|
| Electron Transport Complex III | 1 | 2021 | 4 | 0.190 |
Why?
|
| Electron Transport Complex IV | 1 | 2021 | 14 | 0.190 |
Why?
|
| Electron Transport Complex I | 1 | 2021 | 15 | 0.190 |
Why?
|
| Cell Hypoxia | 1 | 2021 | 42 | 0.190 |
Why?
|
| Mammals | 1 | 2023 | 209 | 0.190 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2021 | 13 | 0.190 |
Why?
|
| Carcinogenesis | 1 | 2022 | 118 | 0.180 |
Why?
|
| Lipid Metabolism | 1 | 2023 | 203 | 0.180 |
Why?
|
| Sirtuins | 1 | 2021 | 26 | 0.180 |
Why?
|
| Caenorhabditis elegans | 2 | 2025 | 623 | 0.180 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2021 | 9 | 0.180 |
Why?
|
| Genomics | 1 | 2024 | 319 | 0.180 |
Why?
|
| Cell Proliferation | 3 | 2024 | 941 | 0.180 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2020 | 4 | 0.180 |
Why?
|
| Metabolomics | 2 | 2018 | 49 | 0.180 |
Why?
|
| Reactive Oxygen Species | 2 | 2018 | 205 | 0.170 |
Why?
|
| Fats | 1 | 2020 | 18 | 0.170 |
Why?
|
| Cell Line | 2 | 2021 | 1983 | 0.170 |
Why?
|
| Liver | 2 | 2022 | 795 | 0.170 |
Why?
|
| Cell Differentiation | 2 | 2023 | 1304 | 0.170 |
Why?
|
| Models, Biological | 1 | 2025 | 1143 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2020 | 179 | 0.160 |
Why?
|
| Histones | 1 | 2023 | 457 | 0.160 |
Why?
|
| Antineoplastic Agents | 3 | 2024 | 628 | 0.160 |
Why?
|
| Insulin Resistance | 1 | 2022 | 392 | 0.160 |
Why?
|
| Cell Survival | 2 | 2018 | 559 | 0.160 |
Why?
|
| Muscle, Skeletal | 2 | 2023 | 674 | 0.160 |
Why?
|
| Homeostasis | 2 | 2018 | 346 | 0.160 |
Why?
|
| 3T3-L1 Cells | 3 | 2024 | 83 | 0.160 |
Why?
|
| Transaminases | 1 | 2018 | 12 | 0.150 |
Why?
|
| Diet | 1 | 2022 | 496 | 0.150 |
Why?
|
| PPAR gamma | 3 | 2024 | 72 | 0.150 |
Why?
|
| Succinic Acid | 1 | 2018 | 11 | 0.150 |
Why?
|
| Female | 9 | 2025 | 30720 | 0.150 |
Why?
|
| Sirtuin 3 | 1 | 2018 | 12 | 0.150 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2020 | 167 | 0.150 |
Why?
|
| Glutamic Acid | 1 | 2018 | 95 | 0.150 |
Why?
|
| Amination | 1 | 2017 | 2 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 651 | 0.140 |
Why?
|
| Indophenol | 1 | 2017 | 1 | 0.140 |
Why?
|
| Glutaminase | 1 | 2017 | 2 | 0.140 |
Why?
|
| Aspartic Acid | 1 | 2017 | 28 | 0.140 |
Why?
|
| Small Molecule Libraries | 1 | 2018 | 55 | 0.140 |
Why?
|
| Glioma | 1 | 2018 | 102 | 0.140 |
Why?
|
| MCF-7 Cells | 1 | 2017 | 65 | 0.140 |
Why?
|
| Biocatalysis | 1 | 2017 | 45 | 0.140 |
Why?
|
| Proline | 1 | 2017 | 42 | 0.140 |
Why?
|
| Biological Transport | 1 | 2018 | 288 | 0.140 |
Why?
|
| Polymerization | 1 | 2017 | 34 | 0.140 |
Why?
|
| Gene Editing | 1 | 2021 | 299 | 0.130 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 140 | 0.130 |
Why?
|
| Organelle Biogenesis | 1 | 2016 | 15 | 0.130 |
Why?
|
| Oxidative Stress | 1 | 2018 | 279 | 0.130 |
Why?
|
| Molecular Structure | 1 | 2017 | 374 | 0.130 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2017 | 59 | 0.130 |
Why?
|
| Carbon | 1 | 2016 | 45 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 635 | 0.130 |
Why?
|
| Adipocytes | 3 | 2024 | 255 | 0.120 |
Why?
|
| Proteome | 1 | 2016 | 141 | 0.120 |
Why?
|
| Citric Acid Cycle | 2 | 2025 | 26 | 0.120 |
Why?
|
| Cell Membrane | 1 | 2017 | 486 | 0.120 |
Why?
|
| Purines | 2 | 2025 | 38 | 0.110 |
Why?
|
| Lymphocyte Activation | 1 | 2016 | 743 | 0.110 |
Why?
|
| Fatty Acids | 2 | 2024 | 191 | 0.110 |
Why?
|
| Mice, Knockout | 3 | 2025 | 1997 | 0.100 |
Why?
|
| Amino Acids | 2 | 2025 | 140 | 0.100 |
Why?
|
| Uncoupling Protein 1 | 2 | 2025 | 50 | 0.100 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 858 | 0.090 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 986 | 0.090 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2025 | 74 | 0.090 |
Why?
|
| Adipose Tissue, White | 2 | 2022 | 86 | 0.080 |
Why?
|
| Proteomics | 2 | 2025 | 263 | 0.080 |
Why?
|
| Male | 6 | 2025 | 27743 | 0.080 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2025 | 6 | 0.060 |
Why?
|
| Oxidative Phosphorylation | 1 | 2025 | 39 | 0.060 |
Why?
|
| DNA Copy Number Variations | 1 | 2025 | 65 | 0.060 |
Why?
|
| Mammary Glands, Human | 1 | 2025 | 53 | 0.060 |
Why?
|
| Selenoproteins | 1 | 2024 | 8 | 0.060 |
Why?
|
| Diet, High-Fat | 1 | 2025 | 163 | 0.060 |
Why?
|
| Sulfides | 1 | 2024 | 23 | 0.060 |
Why?
|
| Uridine Diphosphate Xylose | 1 | 2023 | 6 | 0.060 |
Why?
|
| Oxidoreductases | 1 | 2024 | 64 | 0.050 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2023 | 13 | 0.050 |
Why?
|
| Pulmonary Artery | 1 | 2024 | 88 | 0.050 |
Why?
|
| Heat-Shock Response | 1 | 2023 | 35 | 0.050 |
Why?
|
| Swine | 1 | 2024 | 354 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2022 | 31 | 0.050 |
Why?
|
| Gain of Function Mutation | 1 | 2022 | 12 | 0.050 |
Why?
|
| DNA Replication | 1 | 2024 | 228 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2025 | 883 | 0.050 |
Why?
|
| Receptor, Insulin | 1 | 2022 | 48 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2025 | 391 | 0.050 |
Why?
|
| Cell Death | 1 | 2024 | 271 | 0.050 |
Why?
|
| Sex Factors | 1 | 2025 | 935 | 0.050 |
Why?
|
| Myocardium | 1 | 2024 | 264 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2024 | 289 | 0.050 |
Why?
|
| 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2021 | 3 | 0.050 |
Why?
|
| Antimycin A | 1 | 2021 | 2 | 0.050 |
Why?
|
| Oligomycins | 1 | 2021 | 3 | 0.050 |
Why?
|
| eIF-2 Kinase | 1 | 2021 | 9 | 0.050 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 2021 | 14 | 0.050 |
Why?
|
| Phenotype | 1 | 2025 | 1137 | 0.050 |
Why?
|
| Mice, Congenic | 1 | 2020 | 22 | 0.040 |
Why?
|
| Culture Media | 1 | 2021 | 77 | 0.040 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2021 | 55 | 0.040 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2020 | 14 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2021 | 190 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2022 | 551 | 0.040 |
Why?
|
| Exercise Tolerance | 1 | 2020 | 75 | 0.040 |
Why?
|
| Gene Expression | 1 | 2023 | 809 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 278 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 516 | 0.040 |
Why?
|
| Genome, Human | 1 | 2021 | 224 | 0.040 |
Why?
|
| Insulin | 1 | 2022 | 673 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2021 | 283 | 0.040 |
Why?
|
| Lung | 1 | 2024 | 920 | 0.040 |
Why?
|
| Pregnancy Proteins | 1 | 2018 | 16 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 587 | 0.040 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2018 | 34 | 0.040 |
Why?
|
| Azaserine | 1 | 2018 | 1 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 411 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 584 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2018 | 258 | 0.040 |
Why?
|
| Glycolysis | 1 | 2017 | 54 | 0.030 |
Why?
|
| Isoxazoles | 1 | 2017 | 12 | 0.030 |
Why?
|
| Cellular Reprogramming | 1 | 2017 | 35 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2021 | 333 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 1206 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2018 | 365 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2017 | 97 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 178 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2018 | 377 | 0.030 |
Why?
|
| Epitopes | 1 | 2016 | 286 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 650 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 1553 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 2053 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 1552 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 402 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 623 | 0.020 |
Why?
|
| Mutation | 1 | 2018 | 2456 | 0.020 |
Why?
|